Lawler PR, Berg DD, Park JG, Katz JN, Baird-Zars VM, Barsness GW, et al. The range of cardiogenic shock survival by clinical stage: data from the critical care cardiology trials network registry. Crit Care Med. 2021;49(8):1293–302.

Article  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826.

Article  PubMed  Google Scholar 

van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the american heart association. Circulation. 2017. https://doi.org/10.1161/CIR.0000000000000525.

Article  PubMed  Google Scholar 

Jung C, Fuernau G, De Waha S, Eitel I, Desch S, Schuler G, et al. Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy. Clin Res Cardiol. 2015;104(8):679–87.

Article  PubMed  Google Scholar 

Ostadal P, Rokyta R, Kruger A, Vondrakova D, Janotka M, Smíd O, et al. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial: extra corporeal membrane oxygenation in the therapy of cardiogenic Shock (ECMO-CS). Eur J Heart Fail. 2017;19:124–7.

Article  CAS  PubMed  Google Scholar 

Ouweneel DM, Eriksen E, Sjauw KD, Van Dongen IM, Hirsch A, Packer EJS, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278–87.

Article  PubMed  Google Scholar 

Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al. Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 2023;389:1286–97.

Article  CAS  PubMed  Google Scholar 

Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials. The Lancet. 2023;402:1338–46.

Article  Google Scholar 

Lawler PR, Fan E. Heterogeneity and phenotypic stratification in acute respiratory distress syndrome. Lancet Respir Med. 2018;6(9):651–3.

Article  PubMed  Google Scholar 

Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28(6):1141–8.

Article  CAS  PubMed  Google Scholar 

Zweck E, Thayer KL, Helgestad OKL, Kanwar M, Ayouty M, Garan AR, et al. Phenotyping cardiogenic shock. JAHA. 2021;10(14): e020085.

Article  PubMed  PubMed Central  Google Scholar 

Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94:29–37.

Article  PubMed  Google Scholar 

Lim HS. Phenotyping and hemodynamic assessment in cardiogenic shock: from physiology to clinical application. Cardiol Ther. 2022;11(4):509–22.

Article  PubMed  PubMed Central  Google Scholar 

Toma A, Dos Santos C, Burzyńska B, Góra M, Kiliszek M, Stickle N, et al. Diversity in the expressed genomic host response to myocardial infarction. Circ Res. 2022;131(1):106–8.

Article  CAS  PubMed  Google Scholar 

Lawler PR, Bhatt DL, Godoy LC, Lüscher TF, Bonow RO, Verma S, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113–31.

Article  CAS  PubMed  Google Scholar 

Baran DA, Long A, Badiye AP, Stelling K. Prospective validation of the SCAI shock classification: single center analysis. Catheter Cardiovasc Interv. 2020;96(7):1339–47.

Article  PubMed  PubMed Central  Google Scholar 

Jentzer JC, Soussi S, Lawler PR, Kennedy JN, Kashani KB. Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population. Cathet Cardio Intervent. 2022;99(4):1006–14.

Article  Google Scholar 

Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies. J Am Coll Cardiol. 2022;79(9):933–46.

Article  PubMed  Google Scholar 

Zweck E, Kanwar M, Li S, Sinha SS, Garan AR, Hernandez-Montfort J, et al. Clinical course of patients in cardiogenic shock stratified by phenotype. JACC Heart Failure. 2023

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.

Article  CAS  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022. https://doi.org/10.1161/CIR.0000000000001063

Soussi S, Dos Santos C, Jentzer JC, Mebazaa A, Gayat E, Pöss J, et al. Distinct host-response signatures in circulatory shock: a narrative review. ICMx. 2023;11(1):50.

Article  PubMed  PubMed Central  Google Scholar 

Jentzer JC. Understanding cardiogenic shock severity and mortality risk assessment. Circ Heart Failure. 2020;13(9):e007568.

Article  PubMed  Google Scholar 

Burstein B, Van Diepen S, Wiley BM, Anavekar NS, Jentzer JC. Biventricular function and shock severity predict mortality in cardiac ICU patients. Chest. 2022;161(3):697–709.

Article  PubMed  Google Scholar 

Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, et al. Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Failure. 2020;13(9):1007099.

Article  Google Scholar 

Jentzer JC, Rayfield C, Soussi S, Berg DD, Kennedy JN, Sinha SS, et al. Advances in the staging and phenotyping of cardiogenic shock. JACC Adv. 2022;1(4):100120.

Article  Google Scholar 

Kohsaka S. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165(14):1643.

Article  PubMed  Google Scholar 

Jentzer JC, Lawler PR, Van Diepen S, Henry TD, Menon V, Baran DA, et al. Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes. 2020;13(12):1006956.

Article  Google Scholar 

Merdji H, Curtiaud A, Aheto A, Studer A, Harjola VP, Monnier A, et al. Performance of early capillary refill time measurement on outcomes in cardiogenic shock: an observational, prospective multicentric study. Am J Respir Crit Care Med. 2022;206(10):1230–8.

Article  PubMed  Google Scholar 

Lawler PR, van Diepen S. Toward a broader characterization of macro- and microcirculatory uncoupling in cardiogenic shock. Am J Respir Crit Care Med. 2022;206(10):1192–3.

Article  PubMed  PubMed Central  Google Scholar 

Boyalla V, Gallego-Colon E, Spartalis M. Immunity and inflammation in cardiovascular disorders. BMC Cardiovasc Disord. 2023;23(1):148.

Article  PubMed  PubMed Central  Google Scholar 

Zlatanova I, Pinto C, Silvestre JS. Immune modulation of cardiac repair and regeneration: the art of mending broken hearts. Front Cardiovasc Med. 2016. https://doi.org/10.3389/fcvm.2016.00040/full.

Article  PubMed  PubMed Central  Google Scholar 

Gentek R, Hoeffel G. The innate immune response in myocardial infarction, repair, and regeneration. In: Sattler S, Kennedy-Lydon T, editors. The immunology of cardiovascular homeostasis and pathology. Cham: Springer International Publishing; 2017 [cited 2023 Jul 7]. p. 251–72. (Advances in Experimental Medicine and Biology; vol. 1003). https://doi.org/10.1007/978-3-319-57613-8_12

Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 2002;30(9):1987–94.

Article  CAS  PubMed  Google Scholar 

Kataja A, Tarvasmäki T, Lassus J, Sionis A, Mebazaa A, Pulkki K, et al. Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock—Insights from the CardShock study. Int J Cardiol. 2020; https://www.internationaljournalofcardiology.com/article/S0167-5273(20)33652-4/fulltext

Andrié RP, Becher UM, Frommold R, Tiyerili V, Schrickel JW, Nickenig G, et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012;16(4):R152.

Article  PubMed  PubMed Central  Google Scholar 

Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med. 2003;29(8):1384–9.

Article  PubMed  Google Scholar 

Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol. 2008;97(5):298–305.

Article  CAS  PubMed  Google Scholar 

Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S. Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med. 2009;4(5):403–8.

Article  PubMed  Google Scholar 

Prondzinsky R, Unverzagt S, Lemm H, Wegener NA, Schlitt A, Heinroth KM, et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101(5):375–84.

Article  CAS  PubMed  Google Scholar 

Prondzinsky R, Unverzagt S, Lemm H, Wegener N, Heinroth K, Buerke U, et al. Acute myocardial infarction and cardiogenic shock: Prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β. Med Klin Intensivmed Notfmed. 2012;107(6):476–84.